Natco Pharma up 7%, receives EIR from USFDA for Chennai plant

Moneycontrol BureauShares of Natco Pharma gained 7.4 percent intraday Thursday on receipt of establishment inspection report for its Chennai plant.The company has received a successful establishment inspection report (EIR) from the US food and drug administration (FDA) for its chemical division, Chennai, India.The inspection has been conducted, during the period February 8 - February 12, 2016.Earlier in this month, it had received EIR from the USFDA for its drug manufacturing facility in Kothur Village.At 10:02 hrs Natco Pharma was quoting at Rs 694.15, up Rs 38.95, or 5.94 percent. It has touched a 52-week high of Rs 703.95 on the BSE. Posted by Rakesh Patil